Medical Cannabis is a movement that can’t be stopped

Join host Anna Proske on Market Frontlines for an eye-opening interview with Philip Schetter, CEO of Cantourage Group SE. In this episode, discover how Cantourage built Europe’s leading medical cannabis platform without ever growing a single plant themselves. Learn about their unique manufacturing hub model in Germany, exclusive revenue-sharing partnerships with top-tier global growers, and how they scaled from €50M to nearly €93M in revenue in just one year. Philip explains why they’ve never destroyed a gram of cannabis, how they navigate complex European regulations, and why aging populations and chronic pain management are driving unstoppable demand across the UK, Poland, Austria, Switzerland, and soon France and Spain. Whether you’re an investor, healthcare professional, or simply curious about the future of medical cannabis, this episode delivers unfiltered insights into a company reshaping European pharma.